Amneal Pharmaceuticals (AMRX) announced the launch of mesalamine 800 mg delayed-release tablets, an aminosalicylate indicated for the treatment of moderately active ulcerative colitis in adults ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback